← 홈

프로그램 비교

검색으로 10,000+ 프로그램 중 최대 5개를 골라 PK/PD · 독성 · 임상을 나란히 비교합니다. · 다음 갱신 D-8 · 마지막 7월 21일

현재 선택: 1

프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.

API CSV20행 · 1개 프로그램

표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.

항목
CGTPhase 1
Higher (injection of scAAV2-P1ND4v2 1.0 X10e11vg, injection of scAAV2-P1ND4v2 1.0 X10e11vg (Higher))
Byron Lam·Leber's Hereditary Optic Neuropath…
ORR 0.03%
Overview
Program
injection of scAAV2-P1ND4v2 1.0 X10e11vg (Higher)
Overview
Company
Byron Lam
Overview
Modality
CGT
Overview
Target
Leber's Hereditary Optic Neuropathy
Overview
Indication
Leber's Hereditary Optic Neuropathy
Overview
Phase
PHASE_1
Overview
Status
ACTIVE
MoA
Biomarker
biomarkers in supraventricular tachycardia: An observational study
PK/PD
Species
Rat
PK/PD
Animal (cat.)
Rat
PK/PD
Experiment
pharmacodynamic
Toxicology
Species
Rat
Toxicology
Animal (cat.)
Rat
Toxicology
Major finding
Perforation risk factors in ESR-EB resection of gastric submucosal tumors ≤ 10 mm.. This study aimed to investigate the risk factors for perforation during endoscopic snare resection with an elastic band (ESR-EB) resection of gastric submucosal tumors ≤ 10 mm, providing clinical guidance for preventing intraoperative adverse events. A retrospective study was cond…
Clinical
Primary efficacy
ORR 0.03%
Clinical
ORR
1.03%
Clinical
Result source
ClinicalTrials.gov NCT02161380
Clinical
Data Tier / Score
A · 27
Clinical
Program phase
PHASE_1
Clinical
Clinical sync
2026년 7월 18일 (8일 전)